NL-OMON51699招募中不适用
Brain INvolvement in Dystrophinopathies: BIND: Deep functional phenotyping of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy patients (WP5) Part 2 - BIND
niversity college London0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 64(—)
入选标准
- •For DMD patients:
- •- age 5-17 years
- •- genetically-proven diagnosis of DMD
- •- genetic mutation that abrogates expression of Dp427 alone (assigned in DMD
- •Group 1: Dp427-/Dp140+) or both Dp427 and Dp140 (assigned to DMD Group 2:
- •Dp427-/Dp140-); or all isoforms (assigned to DMD group 3)
- •For BMD patients:
- •- age 18-50 years
- •- genetically-proven diagnosis of BMD
- •- genetic mutation that decreases expression of Dp427 alone (assigned to BMD
- •Group 1), of both Dp427 and Dp140 (assigned to BMD Group 2), or that eliminates
- •expression of Dp140 while preserving expression of Dp427 albeit at reduced
- •levels (assigned to BMD Group 3) or of all the isoforms (assigned to BMD Group
- •For MRI healthy controls:
- •- age 5-50 years
排除标准
- •For DMD and BMD patients:
- •- Lack of a molecular diagnosis of DMD or BMD
- •- Mutation falls outside the regions of interest
- •- Any other severe co-morbidity or planned surgical intervention within 6
- •months from the study
- •- Inability to consent (for parents/guardians and adults) or assent. This will
- •exclude the rare individuals with extremely severe learning disability, as the
- •assent in these patients is impossible (or the consent in the adults); in
- •addition it will not be feasible to perform MRI in this group of patients as we
- •will not administer general anaesthetic. We anticipate this group will be
- •enriched in the genotype lacking all dystrophin isoforms, and it is because of
- •this that we have not indicated what is the precise number of individuals with
- •this genotype to be recruited.
- •- Non-Dutch speakers.
- •For MRI healthy controls:
- •- any muscle disease
- •- a brain disorder (such as severe brain concussion in past history, congenital
- •brain anomalies, epilepsy)
- •- Non-Dutch speakers
- •General exclusion criteria for MRI:
- •- Claustrophobia
- •- Pacemakers and defibrillators
- •- Nerve stimulators
- •- Intracranial clips
- •- Intraorbital or intraocular metallic fragments
- •- Cochlear implants
- •- Ferromagnetic implants (e.g. thoracic implant for scoliosis)
- •- Inability to lie supine for 45 minutes
- •- not having a general practitioner
- •- severe learning disability which will require a general anaesthetic
研究者
相似试验
已完成
不适用
Brain Involvement in Dystrophinopathies Part 2Becker Muscular DystrophyDuchenne Muscular DystrophyNCT04668716Great Ormond Street Hospital for Children NHS Foundation Trust339
已完成
不适用
Brain Involvement in Dystrophinopathies Part 1Becker Muscular DystrophyDuchenne Muscular DystrophyNCT04583917Great Ormond Street Hospital for Children NHS Foundation Trust377
已完成
不适用
Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up StudyMyotonic Dystrophy 1Myotonic Dystrophy 2NCT02729597University Hospital, Bonn49
已完成
不适用
evaluation of CNS in muscular dystrophyJPRN-UMIN000014250Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata30
进行中(未招募)
不适用
BRAIN DERIVED NEUROTROPHIC FACTOR AND MAJOR DEPRESSIVE DISORDER TREATMENT: CLINICAL PSYCHOLOGICAL AND PSYCHOPHARMACOTHERAPIC EVALUATIONS - NDMajor Depressive Disorder (single or recurrent episode)MedDRA version: 9.1Level: LLTClassification code 10004940Term: Bipolar II disorderEUCTR2008-008918-39-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
